Jeanne Loring, a co-founder of Aspen Neuroscience, is stepping down from her role as its chief scientific officer.
The La Jolla, CA-based company said Loring—professor emeritus at the Scripps Research Institute, where her work on the genomics of induced pluripotent stem cells laid the foundation for the company’s launch—will become a special advisor to the company’s research and development committee.
Earlier this year Aspen raised $70 million to advance its efforts to develop neuron replacement therapies that use a patient’s own living cells to treat Parkinson’s disease.
Sponsored · Webinar
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
Eurofins DiscoverX
From Our Editors · Podcast
Becoming the Cell & Gene Therapy Hub
Xconomy Insight · Special Report
Insights, wisdom, and inspiration on what it takes
